Biography
Dr. Wei Rui is a distinguished Director of Medical Oncology at Sir Run Run Shaw Hospital, Zhejiang University with 19 years of dedicated clinical practice. Over the course of an extensive career, Wei Rui has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Wei Rui specializes in the diagnosis and management of complex medical conditions, with particular expertise in Lung cancer, Colorectal cancer, Hepatocellular carcinoma, Stereotactic radiotherapy, CAR-T cell therapy. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Wei Rui for the following conditions and procedures:
- Lung cancer
- Colorectal cancer
- Hepatocellular carcinoma
- Stereotactic radiotherapy
- CAR-T cell therapy
Education & Training
- MD Peking University Health Science Center · Fellowship MD Anderson Cancer Center
Professional Credentials & Memberships
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO) Affiliate
International Patient Care
Dr. Wei Rui communicates with patients in English, Chinese, Japanese, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Peking University Health Science Center · Fellowship MD Anderson Cancer Center
Certifications
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO) Affiliate